Ameriprise Financial Inc. grew its holdings in BlackRock Health Sciences Trust (NYSE:BME – Free Report) by 5.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 172,829 shares of the company’s stock after acquiring an additional 8,622 shares during the quarter. Ameriprise Financial Inc.’s holdings in BlackRock Health Sciences Trust were worth $6,554,000 as of its most recent SEC filing.
A number of other institutional investors also recently modified their holdings of BME. Raymond James Financial Inc. acquired a new position in BlackRock Health Sciences Trust in the fourth quarter valued at about $3,250,000. Janney Montgomery Scott LLC raised its stake in BlackRock Health Sciences Trust by 40.5% in the fourth quarter. Janney Montgomery Scott LLC now owns 32,787 shares of the company’s stock valued at $1,244,000 after purchasing an additional 9,455 shares in the last quarter. Comerica Bank raised its stake in BlackRock Health Sciences Trust by 13.1% in the fourth quarter. Comerica Bank now owns 4,454 shares of the company’s stock valued at $169,000 after purchasing an additional 517 shares in the last quarter. First Trust Advisors LP raised its stake in BlackRock Health Sciences Trust by 6.1% in the fourth quarter. First Trust Advisors LP now owns 6,856 shares of the company’s stock valued at $260,000 after purchasing an additional 393 shares in the last quarter. Finally, Invesco Ltd. raised its stake in BlackRock Health Sciences Trust by 8.9% in the fourth quarter. Invesco Ltd. now owns 223,316 shares of the company’s stock valued at $8,470,000 after purchasing an additional 18,213 shares in the last quarter.
BlackRock Health Sciences Trust Stock Down 0.7%
BME stock opened at $35.50 on Friday. The business has a 50-day simple moving average of $36.85 and a 200 day simple moving average of $38.58. BlackRock Health Sciences Trust has a 52 week low of $34.18 and a 52 week high of $42.64.
BlackRock Health Sciences Trust Announces Dividend
About BlackRock Health Sciences Trust
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
Recommended Stories
- Five stocks we like better than BlackRock Health Sciences Trust
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Turbulence for Joby Shares: What’s Behind the Recent Dip?
- How to Use the MarketBeat Excel Dividend Calculator
- Why Carnival Could Be the Ultimate Non-Tech Growth Stock
- What Investors Need to Know to Beat the Market
- Super Micro Computer Stock Clears New Path Higher on Saudi Orders
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.